Search Results - "Ten CATE, H."

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories by Magnette, A, Chatelain, M, Chatelain, B, Ten Cate, H, Mullier, F

“…Ensuring quality has become a daily requirement in laboratories. In haemostasis, even more than in other disciplines of biology, quality is determined by a…”
Get full text

Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa by VAN DER MEIJDEN, P. E. J., VAN SCHILFGAARDE, M., VAN OERLE, R., RENNÉ, T., TEN CATE, H., SPRONK, H. M. H.

“…See also Shapiro S, Laffan M. Making contact with microparticles. This issue, pp 1352–4. Summary.  Background:  The procoagulant properties of microparticles…”
Get full text

The impact of blood coagulability on atherosclerosis and cardiovascular disease by LOEFFEN, R., SPRONK, H. M. H., TEN CATE, H.

“…Although the link between blood coagulation and atherogenesis has been long postulated, only recently, and through the extensive work on transgenic mice,…”
Get full text

Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease by Alnima, T., Meijer, R. I., Spronk, H. M.H., Warlé, M., Cate, H. ten

“…Abstract Peripheral artery disease (PAD) is a major health problem with increased cardiovascular mortality, morbidity and disabling critical limb threatening…”
Get full text

Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method by LOEFFEN, R., KLEINEGRIS, M.‐C. F., LOUBELE, S. T. B. G., PLUIJMEN, P. H. M., FENS, D., van OERLE, R., ten CATE, H., SPRONK, H. M. H.

“…Background: Thrombin generation assays are sensitive methods for assessment of the overall clotting potential of plasma, but, despite their common use in…”
Get full text

Pleiotropic effects of the hemostatic system by Kremers, B. M. M., ten Cate, H., Spronk, H. M. H.

“…Summary Atherothrombosis is characterized by the inflammatory process of atherosclerosis combined with a hypercoagulable state leading to superimposed thrombus…”
Get full text

Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope by D'Alessandro, E., Posma, J.J.N., Spronk, H.M.H., ten Cate, H.

“…Blood coagulation comprises a complex cellular and molecular mechanism that maintains vascular integrity, protects against bleeding (hemostasis) and responds…”
Get full text

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory by Hardy, M, Lecompte, T, Douxfils, J, Lessire, S, Dogné, J M, Chatelain, B, Testa, S, Gouin-Thibault, I, Gruel, Y, Medcalf, R L, Ten Cate, H, Lippi, G, Mullier, F

“…Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory response, disordered hemostasis and high thrombotic risk. A high incidence of…”
Get full text

Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease by Kremers, B. M. M., Posma, J. N., Heitmeier, S., Glunz, J., ten Cate, H., Pallares Robles, A., Daemen, J. H. C., ten Cate-Hoek, A. J., Mees, B. M. E., Spronk, H. M. H.

“…Peripheral artery disease (PAD) patients have an increased cardiovascular risk despite pharmacological treatment strategies. Biomarker research improving risk…”
Get full text

Coagulation and inflammation in long‐term cancer survivors: results from the adult population by Panova‐Noeva, M., Schulz, A., Arnold, N., Hermanns, M. I., Prochaska, J. H., Laubert‐Reh, D., Spronk, H. M., Blettner, M., Beutel, M., Pfeiffer, N., Münzel, T., Lackner, K. J., ten Cate, H., Wild, P. S.

“…Essentials The increase of cancer survival remains curtailed by cardiovascular mortality. We studied a large range of inflammatory and coagulation biomarkers…”
Get full text

Coagulation factors and the protein C system as determinants of thrombin generation in a normal population by DIELIS, A. W. J. H., CASTOLDI, E., SPRONK, H. M. H., VAN OERLE, R., HAMULYÁK, K., TEN CATE, H., ROSING, J.

“…Background: Thrombin generation is a powerful tool to probe overall plasma coagulability. Objective: To determine which plasma factors influence the various…”
Get full text

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel by BOUMAN, H. J., PARLAK, E., VAN WERKUM, J. W., BREET, N. J., TEN CATE, H., HACKENG, C. M., TEN BERG, J. M., TAUBERT, D.

“…Background: Multiple platelet function tests claim to be P2Y12‐pathway specific and capable of capturing the biological activity of clopidogrel…”
Get full text

Randomized clinical trial of biodegradeable intraluminal sheath to prevent anastomotic leak after stapled colorectal anastomosis by Bakker, I. S., Morks, A. N., ten Cate Hoedemaker, H. O., Burgerhof, J. G. M., Leuvenink, H. G., van Praagh, J. B., Ploeg, R. J., Havenga, K., Bakker, I. S., Morks, A. N., ten Cate Hoedemaker, H. O., Leuvenink, H. G., Ploeg, R. J., Havenga, K., van Etten, B., Lange, J. F. M., Hemmer, P. H. J., Burgerhof, J. G. M., Sonneveld, D. J. A., Tanis, P. J., Wegdam, J. A., Jonk, A., Lutke Holzik, M. F., Bosker, R. J. I., Lamme, B., Spillenaar Bilgen, E. J., Bremers, A. J., van der Mijle, H. C., Hoff, C., de Vries, D. P., Logeman, F., Sietses, C., Lesanka Versluijs‐Ossewaarde, F. N., Leijtens, J. W., Tobon Morales, R. E., Neijenhuis, P. A., Kloppenberg, F. W., Schasfoort, R., Bleeker, W. A., Hess, D., Rosman, C., Wit, F., Ton van Engelenburg, K. C., Pronk, A., Bonsing, B. A., Dekker, J. W., Consten, E. C., Patijn, G. A., Bogdan Rajcs, S., Csapó, Z., Bálint, A., Harsányi, L., István, G., Horisberger, K., Bader, F., Kutup, A., Mariette, C., Cebrián, F.

“…Background Anastomotic leakage is a potential major complication after colorectal surgery. The C‐seal was developed to help reduce the clinical leakage rate…”
Get full text

Clinical and economic impact of compression in the acute phase of deep vein thrombosis by Amin, E. E., Joore, M. A., ten Cate, H., Meijer, K., Tick, L. W., Middeldorp, S., Mostard, G. J. M., ten Wolde, M., van den Heiligenberg, S. M., van Wissen, S., van de Poel, M. H. W., Villalta, S., Serné, E. H., Otten, H.‐M., Klappe, E. H., Prandoni, P., ten Cate‐Hoek, A. J.

“…Essentials The value of compression therapy in acute phase of deep vein thrombosis is still unclear. Patients with deep vein thrombosis received acute…”
Get full text

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care by Willems, R A L, Michiels, N, Lanting, V R, Bouwense, S, van den Broek, B L J, Graus, M, Klok, F A, Groot Koerkamp, B, de Laat, B, Roest, M, Wilmink, J W, van Es, N, Mieog, J S D, Ten Cate, H, de Vos-Geelen, J

“…Recent studies have shown that patients with pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant chemo(radio)therapy followed by surgery have an…”
Get full text

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements by Giesen, P. L. A, Gulpen, A. J. W, van Oerle, R, ten Cate, H, Nagy, M, Spronk, H. M. H

“…Abstract Background Thrombin generation (TG) assessed by Calibrated Automated Thrombogram (CAT-I) reflects the overall capacity of plasma to generate thrombin,…”
Get full text

Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study by Kremers, B M M, Daemen, J H C, Ten Cate, H, Spronk, H M H, Mees, B M E, Ten Cate-Hoek, A J

“…Patients with peripheral artery disease (PAD) are treated with preventive strategies to improve the cardiovascular risk. The incidence of cardiovascular events…”
Get full text

Factor XII activation is essential to sustain the procoagulant effects of particulate matter by KILINÇ, E., VAN OERLE, R., BORISSOFF, J. I., OSCHATZ, C., GERLOFS‐NIJLAND, M. E., JANSSEN, N. A., CASSEE, F. R., SANDSTRÖM, T., RENNÉ, T., TEN CATE, H., SPRONK, H. M. H.

“…See also Mutch NJ. Emerging roles for factor XII in vivo. This issue, pp 1355–8. Summary.  Background: Particulate matter (PM) is a key component of ambient…”
Get full text

ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock by KREMER HOVINGA, J. A., ZEERLEDER, S., KESSLER, P., ROMANI DE WIT, T., VAN MOURIK, J. A., HACK, C. E., TEN CATE, H., REITSMA, P. H., WUILLEMIN, W. A., LÄMMLE, B.

“…Background: Insufficient control of von Willebrand factor (VWF) multimer size as a result of severely deficient ADAMTS‐13 activity results in thrombotic…”
Get full text

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) by ten Cate, V, ten Cate, H, Verheugt, F. W. A

“…There are over 385,000 cases of atrial fibrillation (AF) in the Netherlands, with over 45,000 new cases each year. Among other things, AF patients are at high…”
Get full text